Journal of Postgraduate Medicine
 Open access journal indexed with Index Medicus & ISI's SCI  
Users online: 3615  
Home | Subscribe | Feedback | Login 
About Latest Articles Back-Issues Articlesmenu-bullet Search Instructions Online Submission Subscribe Etcetera Contact
 :: Next article
 :: Previous article 
 :: Table of Contents
 ::  Similar in PUBMED
 ::  Search Pubmed for
 ::  Search in Google Scholar for
 ::Related articles
 ::  Article in PDF (193 KB)
 ::  Citation Manager
 ::  Access Statistics
 ::  Reader Comments
 ::  Email Alert *
 ::  Add to My List *
* Registration required (free) 

  IN THIS Article
 ::  References

 Article Access Statistics
    PDF Downloaded146    
    Comments [Add]    
    Cited by others 10    

Recommend this journal


Year : 2002  |  Volume : 48  |  Issue : 4  |  Page : 327

Methylene blue as treatment for contrast medium-induced anaphylaxis.

Correspondence Address:
P R Evora

Login to access the Email id

Source of Support: None, Conflict of Interest: None

PMID: 12571397

Rights and PermissionsRights and Permissions

Keywords: Anaphylaxis, chemically induced,drug therapy,Contrast Media, adverse effects,Coronary Angiography, adverse effects,Human, Methylene Blue, therapeutic use,

How to cite this article:
Evora P R, Oliveira Neto A M, Duarte N M, Vicente W V. Methylene blue as treatment for contrast medium-induced anaphylaxis. J Postgrad Med 2002;48:327

How to cite this URL:
Evora P R, Oliveira Neto A M, Duarte N M, Vicente W V. Methylene blue as treatment for contrast medium-induced anaphylaxis. J Postgrad Med [serial online] 2002 [cited 2023 Jun 2];48:327. Available from:


Nitric oxide seems to play an important pathophysiological role in modulating the systemic changes associated with anaphylaxis.[1] Considering nitric oxide to be the final mediator of vasoplegia, we have used methylene blue to treat anaphylactic shock secondary to radio-contrast material and penicillin[2] in three patients, with a good immediate response. We have also used the drug to treat vasoplegia in cardiac surgery.[3],[4],[5],[6]

Three patients who developed anaphylactic shock following injection of radiocontrast media during coronary angiography were treated with an intravenous bolus of methylene blue (1.5-2 mg/kg). The drug was administered to two patients after hydrocortisone (2 gm) and adrenaline (4-5 mg) failed to provide the necessary response. The third patient received methylene blue alone for the treatment of anaphylactic shock. Injection of methylene blue was associated with prompt improvement in circulatory status. It was possible for us to monitor circulatory status as the procedure was undertaken in the cardiovascular catheterisation laboratory.

Side effects in the form of nodal rhythm and chest pain were observed in one patient each. The nodal rhythm that occurred during methylene blue infusion reverted spontaneously to normal rhythm within a minute.[2] Another hypertensive patient, who had anaphylactic shock during CT scan, complained of chest pain during the methylene blue infusion, but as no ECG changes ensued coronary vasodilators were not employed. We stress that the physiopathology of the ECG changes (nodal rhythm) and the chest pain episode they could be attributed either to the methylene blue infusions or to the radiocontrast agent used.

Methylene blue has been successfully used in the treatment of several disorders such as sepsis, SIRS, anaphylactic shock, and for reversion of methemoglobinaemia in the dose of 1-2 mg/kg intravenously.[2],[3],[4],[5],[6] Although corticosteroids, adrenaline, oxygen and volume expanders have been used in the treatment of anaphylactic shock with a great deal of success, we wish to share our experience regarding the use of methylene blue so that it can be considered as a treatment option in situations where the above measures fail to elicit the desired response.

We concede that the hypothesis of nitric oxide being a mediator of anaphylaxis, on which the use of methylene blue is based, is largely unproven. In addition, there are no studies that have compared the efficacy and safety of methylene blue vis-à-vis conventional methods of management. In fact, we are not sure whether ethical considerations will permit conduct of such a study. Methylene blue has some side effects as well. However, our clinical experience reported previously[2],[3],[4],[5] and in this communication; and the results of animal studies conducted by us (unpublished data) make us believe that methylene blue is likely to be safe and effective in the treatment of anaphylactic shock although information on both efficacy and safety needs to be generated on an ongoing basis. We have experienced seven such occasions in the last 16 years, when a patient with anaphylactic shock did not respond to the conventional methods. Our experience with methylene blue may be of use to physicians who deal with such situations.

 :: References Top

1.Kaeser P, Hammann C, Luthi F, Enrico JF. Anaphylactic shock. Schweiz Rundsch Med Prax 1995;84:1307-13.  Back to cited text no. 1    
2.Evora PR, Roselino CH, Schiavetto PM. Methylene blue in anaphylactic shock. Ann Emerg Med 1997;30:240.  Back to cited text no. 2    
3.Andrade JCS, Batista Filho ML, Evora PR, Tavares JR, Buffolo E, Ribeiro EE et al. Methylene blue administration in the treatment of the vasoplegic syndrome after cardiac surgery. Rev Bras Cir Cardiovasc 1996;11:107-14.  Back to cited text no. 3    
4.Evora PR, Ribeiro PJ, Andrade JCS. Methylene blue administration in SIRS after cardiac operations. Ann Thorac Surg 1997;63:112-3.  Back to cited text no. 4    
5.Evora PR. Should methylene blue be the drug of choice to treat vasoplegias caused by cardiopulmonary bypass and anaphylactic shock? J Thorac Cardiovasc Surg 2000;119:632-4.  Back to cited text no. 5    
6.Viaro F, Dalio MB, Evora PR. Catastrophic cardiovascular adverse reactions to protamine are nitric oxide/cyclic guanosine monophosphate dependent and endothelium mediated: should methylene blue be the treatment of choice? Chest 2002;122:1061-6.  Back to cited text no. 6    

This article has been cited by
1 Methylene blue for vasoplegic syndrome treatment in heart surgery. Fifteen years of questions, answers, doubts and certainties | [Azul de metileno no tratamento da síndrome vasoplégica em cirurgia cardíaca. quinze anos de perguntas, respostas, dúvidas e certezas]
Evora, P.R.B., Ribeiro, P.J.F., Vicente, V.A., dos Reis, C.L., Rodrigues, A.J., Menardi, A.C., Alves Jr., L.,Bassetto, S.
Brazilian Journal of Cardiovascular Surgery. 2009; 24(3): 279-288
2 Intraoperative methylene blue sentinel lymph node mapping in colorectal cancer
Chan SH, Ng C, Looi LM
ANZ JOURNAL OF SURGERY. 2008; 78(9): 775-779
3 Methylene blue and vasoplegia: Who, when, and how?
Stawicki SP, Sims C, Sarani B, et al.
4 Hemodynamic and vascular endothelium function studies in healthy pigs after intravenous bolus infusion of methylene blue | [Estudos hemodinâmicos e da função endotelial em porcas saudáveis após injeção em bolus endovenoso de azul de metileno]
Menardi, A.C., Viaro, F., Vicente, W.V.D.A., Rodrigues, A.J., Évora, P.R.B.
Arquivos Brasileiros de Cardiologia. 2006; 87(4): 477-483-+525-532
5 The Guanylyl cyclase inhibition by MB as vasoplegic circulatory shock therapeutical target
Evora PRB, Viaro F
CURRENT DRUG TARGETS. 2006; 7 (9): 1195-1204
6 The use of methylene blue in the treatment of anaphylactic shock induced by compound 48/80: Experimental studies in rabbits
Buzato MAS, Viaro F, Piccinato CE, Evora PRB
SHOCK. 2005; 23 (6): 582-587
7 Methylthioninium chloride: pharmacology and clinical applications with special emphasis on nitric oxide mediated vasodilatory shock during cardiopulmonary bypass
Faber P, Ronald A, Millar BW
ANAESTHESIA. 2005; 60 (6): 575-587
8 Methylene blue to treat anaphylaxis during anesthesia. Case report
Stocche, R.M., Garcia, L.V., Paulino Dos Reis, M., Klamt, J.G., Évora, P.R.B.
Revista Brasileira de Anestesiologia. 2004; 54(6): 809-814
9 Prolonged postoperative disorientation after methylene blue infusion during parathyroidectomy
Bach KK, Lindsay FW, Berg LS, et al
Anesthesia and Analgesia. 2004; 99(5): 1573-1574
10 Methylene blue: An effective treatment for contrast medium-induced anaphylaxis
Oliveira Neto AM, Duarte NM, Vicente WVA, et al
Medical Science Monitor. 2003; 96(11): CS102-CS106


Print this article  Email this article
Previous article Next article
Online since 12th February '04
© 2004 - Journal of Postgraduate Medicine
Official Publication of the Staff Society of the Seth GS Medical College and KEM Hospital, Mumbai, India
Published by Wolters Kluwer - Medknow